Anti-LHFPL1 monoclonal antibody

Pre-made anti-LHFPL1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to LHFPL1/LHFPL1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1086-Ab-1/ GM-Tg-hg-IP1086-Ab-2Anti-Human LHFPL1 monoclonal antibodyHuman
GM-Tg-rg-IP1086-Ab-1/ GM-Tg-rg-IP1086-Ab-2Anti-Rat LHFPL1 monoclonal antibodyRat
GM-Tg-mg-IP1086-Ab-1/ GM-Tg-mg-IP1086-Ab-2Anti-Mouse LHFPL1 monoclonal antibodyMouse
GM-Tg-cynog-IP1086-Ab-1/ GM-Tg-cynog-IP1086-Ab-2Anti-Cynomolgus/ Rhesus macaque LHFPL1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1086-Ab-1/ GM-Tg-felg-IP1086-Ab-2Anti-Feline LHFPL1 monoclonal antibodyFeline
GM-Tg-cang-IP1086-Ab-1/ GM-Tg-cang-IP1086-Ab-2Anti-Canine LHFPL1 monoclonal antibodyCanine
GM-Tg-bovg-IP1086-Ab-1/ GM-Tg-bovg-IP1086-Ab-2Anti-Bovine LHFPL1 monoclonal antibodyBovine
GM-Tg-equg-IP1086-Ab-1/ GM-Tg-equg-IP1086-Ab-2Anti-Equine LHFPL1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1086-Ab-1/ GM-Tg-hg-IP1086-Ab-2; GM-Tg-rg-IP1086-Ab-1/ GM-Tg-rg-IP1086-Ab-2;
GM-Tg-mg-IP1086-Ab-1/ GM-Tg-mg-IP1086-Ab-2; GM-Tg-cynog-IP1086-Ab-1/ GM-Tg-cynog-IP1086-Ab-2;
GM-Tg-felg-IP1086-Ab-1/ GM-Tg-felg-IP1086-Ab-2; GM-Tg-cang-IP1086-Ab-1/ GM-Tg-cang-IP1086-Ab-2;
GM-Tg-bovg-IP1086-Ab-1/ GM-Tg-bovg-IP1086-Ab-2; GM-Tg-equg-IP1086-Ab-1/ GM-Tg-equg-IP1086-Ab-2
Products NameAnti-LHFPL1 monoclonal antibody
Formatmab
Target NameLHFPL1
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-LHFPL1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1086-Ag-1Recombinant multi-species LHPL1/ LHFPL1 protein


    Target information

    Target IDGM-IP1086
    Target NameLHFPL1
    Gene ID340596,237091,300286,707492,492075,101096451,781310,100054127
    Gene Symbol and SynonymsLhfp,LHFPL1
    Uniprot AccessionQ86WI0,Q80WE5
    Uniprot Entry NameLHPL1_HUMAN,LHPL1_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000182508
    Target ClassificationN/A

    The target: LHFPL1, gene name: LHFPL1, also named as . This gene is a member of the lipoma HMGIC fusion partner (LHFP) gene family, which is a subset of the superfamily of tetraspan transmembrane protein encoding genes. Mutations in one LHFP-like gene result in deafness in humans and mice, and a second LHFP-like gene is fused to a high-mobility group gene in a translocation-associated lipoma. Alternatively spliced transcript variants have been found, but their biological validity has not been determined. .



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.